|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 221.38 USD | +0.03% |
|
-.--% | +0.22% |
| 01-08 | Cidara Therapeutics, Inc.(NasdaqCM:CDTX) dropped from Russell 2000 Value Benchmark | CI |
| 01-08 | Cidara Therapeutics, Inc.(NasdaqCM:CDTX) dropped from Russell 2500 Value Benchmark | CI |
Performance
| 1 day | +0.03% | ||
| Current year | +0.22% | ||
| 1 year | +338.07% | ||
| 3 years | +879.56% | ||
| 5 years | +525.37% | ||
| 10 years | +2.11% |
Volumes
marketsDaily volume
2,691,011
Estimated daily volume
2,691,011
Record volume 1
17,289,018
Record volume 2
6,741,757
Record volume 3
5,488,864
Capital turnover ratio
0
Basic data
Market Cap (USD)
6,974,419,277
Net sales ()
1,275,000
Number of employees
38
Sales / Employee (USD)
33,553
Indicators
Moving average 5 days
221.24
Moving average 100 days
134.42
Price spread / (MMA5)
-0.06%
Price spread / (MMA100)
-39.28%
STIM
RSI 9 days
0
RSI 14 days
0
Historical Quotes: Cidara Therapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Course Extremes
| Current year | 220.47 |  | 221.42 |
| 1 year | 50.25 | | 221.42 |
| 3 years | 10 | | 221.42 |
| 5 years | 8 | | 221.42 |
| 10 years | 8 | | 259 |
Monthly variations
Annual variations
| 2026 | +0.22% | ||
| 2025 | +721.76% | ||
| 2024 | +69.27% | ||
| 2023 | +4.98% | ||
| 2022 | -40.45% | ||
| 2021 | -36.50% | ||
| 2020 | -47.92% | ||
| 2019 | +63.40% | ||
| 2018 | -65.44% | ||
| 2017 | -34.62% | ||
| 2016 | -39.39% | ||
| 2015 | +7.25% |
- Stock Market
- Stocks
- CDTX Stock
- Quotes Cidara Therapeutics
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
